AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Sarepta Therapeutics, Inc. (SRPT) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Sarepta Therapeutics, Inc. (SRPT) stock worth $1K-$15K in a STOCK Act filing on Jan 6, 2020.
The trade happened on Dec 13, 2019, 24 days before it was made public.
SRPT has moved -86.7% since the trade date, from $132.05 to $17.50 (Oct 2, 2026 close).
- Traded
- Dec 13, 2019
- Disclosed
- Jan 6, 2020
- Filing delay
- 24 days
- Price since
- -86.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (29)
- SellABMD$1K-$15KJan 6, 2020
- SellBBVA$1K-$15KJan 6, 2020
- SellBEN$1K-$15KJan 6, 2020
- SellBIDU$1K-$15KJan 6, 2020
- SellBKNG$1K-$15KJan 6, 2020
- BuyBMRN$1K-$15KJan 6, 2020
- BuyBMRN$1K-$15KJan 6, 2020
- SellCCL$1K-$15KJan 6, 2020
- SellCENT$1K-$15KJan 6, 2020
- SellCENTA$1K-$15KJan 6, 2020
- SellCHL$1K-$15KJan 6, 2020
- SellCMP$1K-$15KJan 6, 2020
- BuyDASTY$1K-$15KJan 6, 2020
- SellDNTUY$1K-$15KJan 6, 2020
- SellDRQ$1K-$15KJan 6, 2020
- SellEXAS$1K-$15KJan 6, 2020
- SellICE$1K-$15KJan 6, 2020
- SellIFNNY$1K-$15KJan 6, 2020
- SellKMTUY$1K-$15KJan 6, 2020
- SellMTDR$1K-$15KJan 6, 2020
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.